Chemical Name |
Almotriptan D6 |
Alternate Names |
Almotriptan Stable Isotopes, Stable Isotopes of Almotriptan |
CAT No. |
CS-CX-00079
|
CAS Registry# |
1020764-56-0 |
Category |
Stable Isotopes |
Stock |
Enquire
|
Mol. Wt. |
Not Available |
Mol. For. |
Not Available
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Almotriptan |
Smileys |
O=[S](CC1=CC=C2C(C(CCN(C([2H])([2H])[2H])C([2H])([2H])[2H])=CN2)=C1)(N3CCCC3)=O |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Almotriptan D6 is a deuterated form of Almotriptan, a selective serotonin receptor agonist used to treat migraines. The deuterated form, Almotriptan D6, is used in pharmacokinetic and pharmacodynamic studies to determine how the drug is metabolized and how it interacts with receptors in the body.
Chemically, Almotriptan D6 is a triptan derivative with a molecular formula of C17H18D6N3O2S. It has a molecular weight of 334.52 g/mol and a melting point of 139-140°C. Like Almotriptan, Almotriptan D6 binds to serotonin receptors in the brain, causing vasoconstriction and reducing inflammation, leading to relief from migraine symptoms.
Almotriptan D6 is usually administered orally in tablet form. Dosages may vary depending on the severity of the migraine and the patient's medical history. Patients with liver or kidney problems may require lower dosages to avoid potential complications.
In conclusion, Almotriptan D6 is a deuterated form of Almotriptan used in pharmacokinetic and pharmacodynamic studies. It works by binding to serotonin receptors in the brain, which reduces inflammation and causes vasoconstriction, leading to relief from migraine symptoms. It is administered orally in tablet form and dosages may vary depending on the patient's medical history.